Safety/efficacy of atezolizumab + bevacizumab during anti‐platelet/anticoagulation therapy in unresectable hepatocellular carcinoma
0
Authors
Michihisa Moriguchi
Michihisa Moriguchi•K Okuda•Tomohisa Takagi
Published
June 4, 2024
Abstract
This study aimed to determine the safety and efficacy of atezolizumab + bevacizumab therapy in hepatocellular carcinoma patients receiving anti-platelet agents or anticoagulants.
